However, BCMA is not uniformly expressed on MM cells, as evidenced by a recent study that screened 85 MM patients and found 33 to be BCMA negative4, thus limiting patient eligibility for BCMA CAR-T-cell therapy. The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.